Abstract
This study shows that two cAMP elevating agents, dibutyryl-cAMP (dbcAMP) and forskolin, regulate the expression of several cytokines and inducible nitric oxide synthase (iNOS) in a different manner. Both dbcAMP and forskolin repressed lipopolysaccharide (LPS)-induced TNF-α expression and enhanced anti-inflammatory cytokine IL-10 level in the BV2 microglia. In contrast, they differentially regulated the iNOS, IL-6 and IL-1β expression levels. DbcAMP increased the IL-1β level without affecting either the IL-6 or iNOS expression, whereas forskolin repressed the IL-6 and iNOS expression level without affecting IL-1β in the LPS-stimulated microglia. Treatment with H89, a specific inhibitor of protein kinase A (PKA), revealed that an enhancement in the IL-10 and IL-1β levels by dbcAMP or forskolin totally depends on the PKA pathway, while changes in the other cytokines and iNOS are independent or only partially dependent on the PKA pathway. These results suggest the diverse regulation of the inflammatory reactions depending on different cAMP elevating agents.
Original language | English |
---|---|
Pages (from-to) | 187-190 |
Number of pages | 4 |
Journal | Neuroscience Letters |
Volume | 356 |
Issue number | 3 |
DOIs | |
State | Published - 19 Feb 2004 |
Bibliographical note
Funding Information:This work was supported by a grant (#00-B-WB-06-A-05) for Women's University from Korea Ministry of Science and Technology to H.S. Kim
Keywords
- Cytokine
- Dibutyryl-cAMP
- Forskolin
- H89
- Inducible nitric oxide synthase
- Microglia
- Protein kinase A
- cAMP elevating agent